Honz Pharmaceutical Co., Ltd. (300086.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.47B
Enterprise Value5.78B
P/E Ratio-13.92
PEG Ratio0.55
Price/Sales Ratio7.62
Price/Book Ratio3.33
Enterprise/Revenue8.71
Enterprise/EBITDA-20.67

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.55
Operating Margin-0.59
AD

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.23

Income Statement

Revenue466.12M
Revenue/Share0.83
Gross Profit252.65M
EBITDA-173.76M
Net Income-230.14M
Diluted EPS-0.51

Balance Sheet

Total Cash16.35M
Total Cash/Share0.04
Total Debt426.33M
Total Debt/Equity0.49
Current Ratio0.46
Book Value Per Share1.95

Price History

52-Week Change-7.17
52-Week High15.19
52-Week Low5.46
Moving Average 50 Days6.5
Moving Average 200 Days8.23

Statistics

Average Volume25.18M
Shares Outstanding455.12M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split Factor3:2
Last Split DateSeptember 30, 2015
AD